Environmental triggers and susceptibility factors in idiopathic granulomatous diseases

Seminars in Respiratory and Critical Care Medicine

Volumn 29, Issue 6, 2008, Pages 610-619

  Spagnolo, Paolo ^a   Richeldi, Luca ^a   Du Bois, Roland M ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

Environment; Genetics; Granuloma; Mycobacteria; Phenotypes; Polymorphisms

Indexed keywords

BLAU SYNDROME; CHURG STRAUSS SYNDROME; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IDIOPATHIC DISEASE; LUNG GRANULOMA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; WEGENER GRANULOMATOSIS;

ANIMALS; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG DISEASES, INTERSTITIAL; MYCOBACTERIUM; PHENOTYPE; RISK FACTORS; SARCOIDOSIS, PULMONARY; SYNDROME;

EID: 61849169527     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0028-1101271     Document Type: Review

References (123)

1. Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 1993;262: 242-244
2. Samuel G, Maier LA. Immunology of chronic beryllium disease. Curr Opin Allergy Clin Immunol 2008;8:126-134
3. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357:2153-2165
4. Siltzbach LE, James DG, Neville E, et al. Course and prognosis of sarcoidosis around the world. Am J Med 1974; 57:847-852
5. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003;361:1111-1118
6. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/ WASOG statement on sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:149-173
7. McGrath DS, Goh N, Foley P, du Bois RM. Sarcoidosis: genes and microbes - soil or seed? Sarcoidosis Vasc Diffuse Lung Dis 2001;18:149-164
8. Moller DR, Chen ES. Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex? Am J Respir Cell Mol Biol 2002;27:391-395
9. Jones CM, Lake RA, Wijeyekoon JB, Mitchell DM, du Bois RM, O'Hehir RE. Oligoclonal V gene usage by T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients. Am J Respir Cell Mol Biol 1996;14:470-477
10. Grunewald J, Wahlstrom J, Berlin M, Wigzell H, Eklund A, Olerup O. Lung restricted T cell receptor AV2S3 + CD4 + T + T cell expansions in sarcoidosis patients with a shared HLA-DR beta chain conformation. Thorax 2002;57:348- 352
11. Forrester JM, Newman LS, Wang Y, King TE Jr, Kotzin BL. Clonal expansion of lung V delta 1 + T cells in pulmonary sarcoidosis. J Clin Invest 1993;91:292-300
12. Grunewald J, Shigematsu M, Nagai S. T cell receptor V gene expression in HLA typed Japanese patients with sarcoidosis. Am J Respir Crit Care Med 1995;151:151-156
13. Grunewald J, Hultman T, Bucht A, et al. Restricted usage of TCR V alpha/J alpha gene segments with different nucleotide but identical amino acid sequences in HLA- DR3 + ve sarcoidosis. Mol Med 1995;1:287-296
14. Kent DC, Houk VN, Slliot RC, Sokolowski JW Jr, Baker JK, Sorensen K. The definitive evaluation of sarcoidosis. Am Rev Respir Dis 1970;101:721-727
15. Drake WP, Pei Z, Pride DT, Collins RD, Cover TL, Blaser MJ. Molecular analysis of sarcoidosis tissues for mycobacterium species DNA. Emerg Infect Dis 2002;8:1334-1341
16. Song Z, Marzilli L, Greenlee BM, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005;201:755-767
17. Yi ES, Lee H, Suh YK, et al. Experimental extrinsic allergic alveolitis and pulmonary angiitis induced by intratracheal or intravenous challenge with Corynebacterium parvum in sensitized rats. Am J Pathol 1996;149:1303-1312
18. Ichiyasu H, Suga M, Matsukawa A, et al. Functional roles of MCP-1 in Propionibacterium acnes-induced, T cell- mediated pulmonary granulomatosis in rabbits. J Leukoc Biol 1999;65:482-491
19. Abe C, Iwai K, Mikami R, Hosoda Y. Frequent isolation of Propionibacterium acnes from sarcoidosis lymph nodes. Zentralbl Bakteriol Mikrobiol Hyg [A] 1984;256:541-547
20. Eishi Y, Suga M, Ishige I, et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 2002;40:198-204
21. Ebe Y, Ikushima S, Yamaguchi T, et al. Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2000;17:256-265
22. Parkes SA, Baker SB, Bourdillon RE, et al. Incidence of sarcoidosis in the Isle of Man. Thorax 1985;40:284-287
23. Kern DG, Neill MA, Wrenn DS, Varone JC. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am Rev Respir Dis 1993;148:974-980
24. Padilla ML, Schilero GJ, Teirstein AS. Donor-acquired sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:18-24
25. Mitchell IC, Turk IL. Observations on the Kveim reaction using an animal model of granulomatous bowel disease. Gut 1991;32:159-162
26. Siltzbach LE. The Kveim test in sarcoidosis: a study of 750 patients. JAMA 1961;178:476-482
27. Munro CS, Mitchell DN. The Kveim response: still useful, still a puzzle. Thorax 1987;42:321-331
28. Rybicki BA, Iannuzzi MC. Epidemiology of sarcoidosis: recent advances and future prospects. Semin Respir Crit Care Med 2007;28:22-35
29. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145:234-241
30. Pietinalho A, Ohmichi M, Hiraga Y, Lofroos AB, Selroos O. The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan: a comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis Vasc Diffuse Lung Dis 1996;13:159-166
31. Rybicki BA, Iannuzzi MC, Frederick MM, et al. Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001; 164:2085-2091
32. Mehra NK, Bovornkitti S. HLA and sarcoidosis. Sarcoidosis 1988;5:87-89
33. McIntyre JA, McKee KT, Loadholt CB, Mercurio S, Lin I. Increased HLA-B7 antigen frequency in South Carolina blacks in association with sarcoidosis. Transplant Proc 1977; 9:173-176
34. Ina Y, Takada K, Yamamoto M, et al. HLA and sarcoidosis in the Japanese. Chest 1989;95:1257-1261
35. Smith MJ, Turton CW, Mitchell DN, et al. Association of HLA-B8 with spontaneous resolution in sarcoidosis. Thorax 1981;36:296-298
36. Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004;169:696-702
37. Ina Y, Takada K, Yamamoto M, et al. HLA and sarcoidosis in the Japanese. Chest 1989;95:1257-1261
38. Nowack D, Goebel KM. Genetic aspects of sarcoidosis: class II histocompatibility antigens and a family study. Arch Intern Med 1987;147:481-483
39. Swider C, Schnittger L, Bogunia-Kubik K, et al. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. Eur Cytokine Netw 1999;10:143-146
40. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997;156:1601-1605
41. Foley PJ, McGrath DS, Puscinska E, et al. Human leukocyte antigen-DRB 1 position 11 residues are a common protective marker for sarcoidosis. Am J Respir Cell Mol Biol 2001;25:272-277
42. Martinetti M, Tinelli C, Kolek V, et al. ''The sarcoidosis map'': a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 1995;152:557-564
43. Rossman MD, Thompson B, Frederick M, et al. HLA- DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003;73:720-735
44. Rybicki BA, Maliarik MJ, Poisson LM, et al. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans. Am J Respir Crit Care Med 2003;167:444-449
45. Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med 2003; 167:1225-1231
46. Voorter CE, Drent M, van den Berg-Loonen EM. Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1*0602- DRB1*150101. Hum Immunol 2005;66:826-835
47. Voorter CE, Drent M, Hoitsma E, Faber KG, van den Berg-Loonen EM. Association of HLA DQB1 0602 in sarcoidosis patients with small fiber neuropathy. Sarcoidosis Vasc Diffuse Lung Dis 2005;22:129-132
48. Sato H, Grutters JC, Pantelidis P, et al. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 2002;27:406- 412
49. Grunewald J, Eklund A. Human leukocyte antigen genes may outweigh racial background when generating a specific immune response in sarcoidosis. Eur Respir J 2001;17:1046-1048
50. Ohta H, Tazawa R, Nakamura A, et al. Acute-onset sarcoidosis with erythema nodosum and polyarthralgia (Lofgren's syndrome) in Japan: a case report and a review of the literature. Intern Med 2006;45:659-662
51. Shammas RL, Movahed A. Sarcoidosis of the heart. Clin Cardiol 1993;16:462-472
52. Lympany PA, Petrek M, Southcott AM, et al. HLA-DPB polymorphisms: Glu 69 association with sarcoidosis. Eur J Immunogenet 1996;23:353-359
53. Maliarik MJ, Chen KM, Major ML, et al. Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis. Am J Respir Crit Care Med 1998;158:111-114
54. Schurmann M, Reichel P, Muller-Myhsok B, et al. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001;164:840-846
55. Iannuzzi MC, Iyengar SK, Gray-McGuire C, et al. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun 2005;6:509-518
56. Valentonyte R, Hampe J, Huse K, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005;37:357-364
57. Rybicki BA, Walewski JL, Maliarik MJ, et al. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet 2005;77:491-499
58. Spagnolo P, Sato H, Grutters JC, et al. Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens 2007;70:219-227
59. Grutters JC, Sato H, Welsh KI, du Bois RM. The importance of sarcoidosis genotype to lung phenotype. Am J Respir Cell Mol Biol 2003;29:S59-S62
60. Spagnolo P, Sato H, Grunewald J, et al. A common haplotype of the C-C chemokine receptor 2 gene and HLA- DRB1*0301 are independent genetic risk factors for Lofgren's syndrome. J Intern Med 2008 May 29 [Epub ahead of print]
61. Spagnolo P, Renzoni EA, Wells AU, et al. C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome. Am J Respir Crit Care Med 2003;168:1162- 1166
62. Valentonyte R, Hampe J, Croucher PJ, et al. Study of C-C chemokine receptor 2 alleles in sarcoidosis, with emphasis on family-based analysis. Am J Respir Crit Care Med 2005; 171:1136-1141
63. Rybicki BA, Maliarik MJ, Poisson LM, Iannuzzi MC. Sarcoidosis and granuloma genes: a family-based study in African-Americans. Eur Respir J 2004;24:251-257
64. Guleva I, Seitzer U. Vitamin D receptor gene polymorphism in patients with sarcoidosis. Am J Respir Crit Care Med 2000;162:760-761
65. Niimi T, Tomita H, Sato S, et al. Vitamin D receptor gene polymorphism in patients with sarcoidosis. Am J Respir Crit Care Med 1999;160:1107-1109
66. Maliarik MJ, Chen KM, Sheffer RG, et al. The natural resistance- associated macrophage protein gene in African Americans with sarcoidosis. Am J Respir Cell Mol Biol 2000;22:672-675
67. Foley PJ, Lympany PS, Puscinska E, Zielinski J, Welsh KI, du Bois RM. Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis. Am J Respir Crit Care Med 1999;160:1009-1014
68. Ishihara M, Ohno S, Mizuki N, et al. Genetic polymorphisms of the major histocompatibility complex- encoded antigen-processing genes TAP and LMP in sarcoidosis. Hum Immunol 1996;45:105-110
69. Schurmann M, Reichel P, Muller-Myhsok B, et al. Angiotensin-converting enzyme (ACE) gene polymorphisms and familial occurrence of sarcoidosis. J Intern Med 2001; 249:77-83
70. McGrath DS, Foley PJ, Petrek M, et al. Ace gene I/D polymorphism and sarcoidosis pulmonary disease severity. Am J Respir Crit Care Med 2001;164:197-201
71. Maliarik MJ, Rybicki BA, Malvitz E, et al. Angiotensin- converting enzyme gene polymorphism and risk of sarcoidosis. Am J Respir Crit Care Med 1998;158:1566-1570
72. Tomita H., Ina Y, Sugiura Y, et al. Polymorphism in the angiotensin-converting enzyme (ACE) gene and sarcoidosis. Am J Respir Crit Care Med 1997;156:255-259
73. Arbustini E, Grasso M, Leo G, et al. Polymorphism of angiotensin- converting enzyme gene in sarcoidosis. Am J Respir Crit Care Med 1996;153:851-854
74. Grutters JC, Sato H, Pantelidis P, et al. Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 2002;165:1119-1124
75. Seitzer U, Swider C, Stuber F, et al. Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokine 1997;9:787-790
76. Spagnolo P, Renzoni EA, Wells AU, et al. C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis. Am J Respir Crit Care Med 2005;172:721-728
77. Petrek M, Drabek J, Kolek V, et al. CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 2000;162:1000-1003
78. Hizawa N, Yamaguchi E, Furuya K, Jinushi E, Ito A, Kawakami Y. The role of the C-C chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population. Am J Respir Crit Care Med 1999; 159:2021-2023
79. Spagnolo P, Sato H, Marshall SE, et al. Association between heat shock protein 70/Hom genetic polymorphisms and uveitis in patients with sarcoidosis. Invest Ophthalmol Vis Sci 2007;48:3019-3025
80. Grutters JC, Sato H, Pantelidis P, et al. Analysis of IL6 and IL1A gene polymorphisms in UK and Dutch patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003;20: 20-27
81. Hutyrova B, Pantelidis P, Drabek J, et al. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002;165:148-151
82. Rybicki BA, Maliarik MJ, Malvitz E, et al. The influence of T cell receptor and cytokine genes on sarcoidosis susceptibility in African Americans. Hum Immunol 1999;60:867-874
83. Pabst S, Baumgarten G, Stremmel A, et al. Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin Exp Immunol 2006;143: 420-426
84. Gazouli M, Koundourakis A, Ikonomopoulos J, et al. CARD15/NOD2, CD14, and toll-like receptor 4 gene polymorphisms in Greek patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006;23:23-29
85. Milman N, Nielsen OH, Hviid TV, Fenger K. CARD15 single nucleotide polymorphisms 8, 12 and 13 are not increased in ethnic Danes with sarcoidosis. Respiration 2007;74:76-79
86. Schurmann M, Valentonyte R, Hampe J, Muller-Quer- nheim J, Schwinger E, Schreiber S. CARD15 gene mutations in sarcoidosis. Eur Respir J 2003;22:748-754
87. Martin TM, Doyle TM, Smith JR, Dinulescu D, Rust K, Rosenbaum JT. Uveitis in patients with sarcoidosis is not associated with mutations in NOD2 (CARD15). Am J Ophthalmol 2003;136:933-935
88. Hattori N, Niimi T, Sato S, et al. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2005;22:27-32
89. Abdallah A, Sato H, Grutters JC, et al. Inhibitor kappa B-alpha IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun 2003;4:450-454
90. Kruit A, Grutters JC, Ruven HJ, et al. Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis. Chest 2006;129:1584-1591
91. Hill MR, Papafili A, Booth H, et al. Functional prostaglandin- endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis. Am J Respir Crit Care Med 2006;174:915-922
92. Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr 1985;107:689-693
93. Tromp G, Kuivaniemi H, Raphael S, et al. Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16. Am J Hum Genet 1996;59:1097-1107
94. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet 2001;29:19-20
95. Rybicki BA, Maliarik MJ, Bock CH, et al. The Blau syndrome gene is not a major risk factor for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:203-208
96. Schurmann M, Valentonyte R, Hampe J, Muller- Quernheim J, Schwinger E, Schreiber S. CARD15 gene mutations in sarcoidosis. Eur Respir J 2003;22:748-754
97. Raphael SA, Blau EB, Zhang WH, Hsu SH. Analysis of a large kindred with Blau syndrome for HLA, autoimmunity, and sarcoidosis. Am J Dis Child 1993;147:842-848
98. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603
99. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-606
100. Brown KK. Pulmonary vasculitis. Proc Am Thorac Soc 2006;3:48-57
101. Savige J, Gillis D, Benson E, et al. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol 1999; 111:507-513
102. Csernok E, Muller A, Gross W. Immunopathology of ANCA-associated vasculitis. Intern Med 1999;38:759-765
103. Keogh KA, Specks U. Churg-Strauss syndrome. Semin Respir Crit Care Med 2006;27:148-157
104. Sable-Fourtassou R, Cohen P, Mahr A, et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005;143:632-638
105. Lane SE, Watts RA, Bentham G, et al. Are environmental factors important in primary systemic vasculitis? A casecontrol study. Arthritis Rheum 2003;48:814-823
106. Wechsler ME, Finn D, Gunawardena D, et al. Churg- Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest 2000;117:708-713
107. Wechsler ME, Garpestad E, Flier SR, et al. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA 1998;279:455-457
108. Vaglio A, Martorana D, Maggiore U, et al. HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum 2007;56:3159-3166
109. Wieczorek S, Hellmich B, Gross WL, Epplen JT. Associations of Churg-Strauss syndrome with the HLA-DRB1 locus, and relationship to the genetics of antineutrophil cytoplasmic antibody-associated vasculitides: comment on the article by Vaglio et al. Arthritis Rheum 2008; 58:329-330
110. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-1107
111. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-498
112. Stone JH, Hoffman GS. Wegener's granulomatosis and lymphomatoid granulomatosis. In: Hocberg MC, Silmon AJ, Smolen JS, Weinblatt ME, Weisman MH, eds. Rheumatology. 3rd ed. New York: Mosby; 2003:1635-1648
113. Popa ER, Stegeman CA, Kallenberg CGM, et al. Staphylococcus aureus and Wegener's granulomatosis. Arthritis Res 2002;4:77-79
114. Lane SE, Watts RA, Bentham G, et al. Are environmental factors important in primary systemic vasculitis? A case- control study. Arthritis Rheum 2003;48:814-823
115. Jagiello P, Gencik M, Arning L, et al. New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum Genet 2004;114:468-477
116. Salmon JE, Edberg JC, Brogle NL, Kimberly RP. Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB: independent mechanisms for differences in human phagocyte function. J Clin Invest 1992;89:1274-1281
117. Dijstelbloem HM, Scheepers RH, Oost WW, et al. Fcgamma receptor polymorphisms in Wegener's granulo- matosis: risk factors for disease relapse. Arthritis Rheum 1999;42:1823-1827
118. Huang D, Zhou Y, Hoffman GS. Pathogenesis: immuno- genetic factors. Best Pract Res Clin Rheumatol 2001;15: 239-258
119. Zhou Y, Giscombe R, Huang D, et al. Novel genetic association of Wegener's granulomatosis with the interleu- kin 10 gene. J Rheumatol 2002;29:317-320
120. Huang D, Giscombe R, Zhou Y, et al. Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin- 1 beta genes are associated with Wegener's granulomatosis. J Rheumatol 2000;27:397-401
121. Allison JP, Krummel MF. The Yin and Yang of T cell costimulation. Science 1995;270:932-933
122. Vang T, Congia M, Macis MD, et al. Autoimmune- associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005;37:1317-1319
123. Jagiello P, Aries P, Arning L, et al. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 2005;52:4039-4043